Most Downloaded Articles – ESMO Open – Journal – Elsevier
ESMO Open is the European Society for Medical Oncology’s online-only, peer-reviewed open access journal, dedicated to publishing high-quality medical research…
Related Articles
Pushing the Boundaries of Liquid Biopsies for Early Precision Intervention
Summary:. Liquid biopsies are emerging as powerful minimally invasive approaches that have the potential to solve several long-standing problems spanning the continuum of cancer care:…
Walmart to close its 51 health centers, virtual care service
Walmart is closing its health centers and virtual care service as the retail giant has struggled to find success with the offerings
Combining TIGIT Blockade with MDSC Inhibition Hinders Breast Cancer Bone Metastasis by Activating Antitumor Immunity
AbstractBone is the most common site of breast cancer metastasis. Bone metastasis is incurable and is associated with severe morbidity. Utilizing an immunocompetent mouse model…
Variant allele frequency: a decision-making tool in precision oncology?
Precision oncology requires additional predictive biomarkers for targeted therapy selection. Variant allele frequency (VAF), measuring the proportion of variant alleles within a genomic locus, provides…
Michael D. : Meet the Master-Hands of Medicine – OncoDaily
Michael D. : Meet the Master-Hands of Medicine / cancer, cancer care, Cancer research, CRISPR, gene therapy, Haydar Frangoul, Michael D., New England Journal
FDA Approves Tisotumab Vedotin for Recurrent or Metastatic Cervical Cancer
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
FDA Approves Tisotumab Vedotin for Recurrent or Metastatic Cervical Cancer
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Lurbinectedin in patients with small cell lung cancer with chemotherapy-free interval ≥30 days and without central nervous metastases
Lurbinectedin was evaluated in a multicenter, open-label, Basket phase 2 study in nine cohorts of patients with different difficult-to-treat tumor types to establish the proof…
Variant allele frequency: a decision-making tool in precision oncology?
Precision oncology requires additional predictive biomarkers for targeted therapy selection. Variant allele frequency (VAF), measuring the proportion of variant alleles within a genomic locus, provides…
Pushing the Boundaries of Liquid Biopsies for Early Precision Intervention
Summary:. Liquid biopsies are emerging as powerful minimally invasive approaches that have the potential to solve several long-standing problems spanning the continuum of cancer care:…